Brazil’s National Supplementary Health Agency (ANS) approved Encorafenib and Cetuximab in combination to treat colorectal cancer effective December 1, 2023. This makes coverage for these…
Brazil expands coverage for MS and Cancer treatment by making Ofatumumab and Intensity Modulated Radiotherapy covered on a compulsory basis beginning September 1, 2023. The…
[UPDATE: June 5, 2023] The treatment for thyroid cancer with levantinibmesylate was recently included in the Minimum Coverage List of Health Procedures and Events, which…
Brazil’s National Agency for Supplementary Health (ANS) ended limitations on the number of consultations and sessions with psychologists, speech therapists, occupational therapists, and physical therapists…
Supplemental health plans in Brazil must now cover specific asthma and cancer drugs. The National Agency for Supplementary Health (ANS) recently approved mandatory coverage for…
Mandatory employee benefits in Brazil include workers’ compensation, disability, life insurance, and Paid Time Off (PTO) in situations such as maternity and paternity leave, among…
CANADA, MEXICO, COLOMBIA & BRAZIL: Alliant’s Americas Webinar Series Learn about the trends happening in the Canadian benefits marketplace from this February 24th webinar presented…
Recently the Brazilian federal government enacted labor measures to tackle the “state of calamity and emergency of public health,” resulting from COVID-19. According to the…
Asinta’s Brazilian Partner, SCIATH, provided this coronavirus update for employers in Brazil. Updated April 2, 2020. Each state in Brazil is deciding how long lockdowns should…